Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Rs 14,000 a month—for weight loss.But, but, but… India’s obesity problem is no small fry, and Big Pharma is racing to cash in ...

Attendance Allowance helps with extra costs if you have a physical or mental disability or illness severe enough that makes ...

As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to ...

Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management.

February was heart months, and this is another column in a series about the major risk factors for heart attacks. According ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

The 2.5 mg vial and 5 mg vial will be available at Rs 3,500 and Rs 4,375, respectively. A spokesperson said as Mounjaro ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

Investing.com -- U.S. pharmaceutical company Eli Lilly (NYSE: LLY) has introduced its diabetes and weight-loss drug Mounjaro ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss the importance of how monitoring your blood sugar levels regularly is important for managing diabetes and how new research shows that ...